Antifungal Activity of Brilacidin, a Nonpeptide Host Defense Molecule.
Antibiotics (Basel, Switzerland) • Vol. 13, Issue 5 • 2024
Brilacidin as a Broad-Spectrum Inhibitor of Enveloped, Acutely Infectious Viruses.
Microorganisms • Vol. 12, Issue 1 • 2023
Identification of Novel, Potent, and Selective Compounds against Malaria Using Glideosomal-Associated Protein 50 as a Drug Target.
ACS omega • Vol. 8, Issue 41 • 2023
Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
Journal of medical virology • Vol. 94, Issue 5 • 2022